JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles

British Journal of Pharmacology

Volumn 130, Issue 4, 2000, Pages 767-776

  Ito, Ken Ichiro ^a   Shigematsu, Sakuji ^a   Sato, Toshiaki ^a   Abe, Takako ^a   Li, Yulong ^a   Arita, Makoto ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Mitochondria; Pharmacological preconditioning; Protein kinase C

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; 5 HYDROXYDECANOIC ACID; ANTIARRHYTHMIC AGENT; CHELERYTHRINE; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN KINASE C INHIBITOR;

ANIMAL TISSUE; ARTICLE; DRUG ANTAGONISM; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034082466     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703373     Document Type: Article

References (26)

1. BUGGE, E. & YTREHUS, K. (1995). Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc. Res., 29, 401-406.
2. BUSH, L.R., ROMSON, J.L., ASH, J.L. & LUCCHESI, B.R. (1982). Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs. J. Cardiovasc. Pharmacol., 4, 285-296.
3. DU TOIT, J. & OPIE, L.H (1992). Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ. Res., 70, 960-967.
4. EHRING, T., BOHM, M. & HEUSCH, G. (1992). The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischaemia. J. Cardiovasc. Pharmacol., 20, 63-74.
5. + channels: possible mechanism of cardioprotection. Circ. Res., 81, 1072-1082.
6. GOTO, M., LIU, Y., YANG, X.M., ARDELL, J.L., COHEN, M.V. & DOWNEY, J.M. (1995). Role of bradykinin in protection of ischaemic preconditioning in rabbit hearts. Circ. Res., 77, 611-621.
7. HACHIDA, M., KANEKO, N., OHKADO, A., HOSHI, H., NONOYAMA, M., SAITO, S., BONKOHARA, Y., HANAYAMA, N., MIYAGISHIMA, M. & KOYANAGI, H. (1997). Significant effect of 1,4-benzothiazepine derivative (K201) in improving myocardial preservation. Transplant. Proc., 29, 1346-1348.
8. HERBERT, J.M., AUGEREAU, J.M., GLEYE, J. & MAFFRAND, J.P. (1990). Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 172, 993-999.
9. ATP channels. Mol. Pharmacol., 55, 1000-1005.
10. + current in human and rabbit ventricular myocytes. Circ. Res., 78, 492-498.
11. INAGAKI, K., KIHARA, Y., HASHIDA, W., IZUMI, T., YONEDA, T., TAKEUCHI, Y., INAGAWA, Y., KATSUO, S., MUSO, E. & SASAYAMA, S. (2000). Anti-ischaemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of δ-isoform of protein kinase C in rat ventricular myocardium. Circulation, 101, 797-804.
12. ITO, K., SATO, T., ABE, T., LI, Y. & ARITA, M. (1998). Anti-stunning effect of JTV-519 in coronary perfused guinea pig ventricular muscles. J. Mol. Cell. Cardiol., 30, A324.
13. KANEKO, N. (1994). New benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action. Drug. Dev. Res., 33, 429-438.
14. KIMURA, J., KAWAHARA, M., SAKAI, E., YATABE, J. & NAKANISHI, H. (1999). Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes. Jpn. J. Pharmacol., 79, 275-281.
15. KITAKAZE, M., HORI, M., MORIOKA, T., MINAMINO, T., TAKASHIMA, S., SATO, H., SHINOZAKI, Y., CHUJO, M., MORI, H. & INOUE, M. (1994). Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of 5′-nucleotidase activity. J. Clin. Invest., 93, 2197-2205.
16. LANGE, R., INGWALL, J., HALE, S.L., ALKER, K.J., BRAUNWALD, E. & KLONER, R.A. (1984). Preservation of high-energy phosphates by verapamil in reperfused myocardium. Circulation, 70, 734-741.
17. 1 adenosine receptors in rabbit heart. Circulation, 84, 350-356.
18. + currents by protein kinase C and adenosine: implications for ischaemic preconditioning. Circ. Res., 78, 443-454.
19. LIU, Y., SATO, T., O'ROURKE, B. & MARBAN, E. (1998). Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation, 97, 2463-2469.
20. MURRY, C.E., JENNINGS, R.B. & REIMER, K.A. (1986). Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation, 74, 1124-1136.
21. NASA, Y., ICHIHARA, K. & ABIKO, Y. (1990). Both d-cis-and 1-cis-diltiazem have anti-ischaemic action in the isolated, perfused working rat heart. J. Pharmacol. Exp. Ther., 255, 680-689.
22. NAYLER, W.G., FERRARI, R. & WILLIAMS, A. (1980). Protective effect of pretreatment with verapamil, nifedipine, and propranolol on mitochondrial function in ischaemic and reperfused myocardium. Am. J. Cardiol., 46, 242-248.
23. 2+ current in guinea-pig heart. Br. J. Pharmacol., 113, 451-456.
24. + channels by protein kinase C. Circ. Res., 83, 110-114.
25. + channels in early phase of reperfusion and its protective role against myocardial stunning. Circulation, 92, 2266-2275.
26. YTREHUS, K., LIU, Y. & DOWNEY, J.M. (1994). Preconditioning protects ischaemic rabbit heart by protein kinase C activation. Am. J. Physiol., 266, H1145-H1152.